What is the main purpose of this Merck 8-K filing?

The primary purpose of this filing is to furnish, as an exhibit, Frequently Asked Questions and Answers (FAQs) previously issued by Schering-Plough Corporation. This is done to ensure broad public dissemination of information that may be of interest to investors, in line with Regulation FD.

Does this filing contain new financial information from Merck?

No, this 8-K filing does not contain new financial statements or specific operational updates directly from Merck. It solely references and provides access to FAQs published by Schering-Plough.

Where can I find the Schering-Plough FAQs mentioned in this filing?

The Schering-Plough FAQs dated May 28, 2008, are furnished as Exhibit 99.1 to this 8-K and are also available on the Schering-Plough website at www.schering-plough.com under the 'Investor Relations/Investor FAQs' section.

Is Merck obligated to update the information in the Schering-Plough FAQs?

No, Merck explicitly states that it undertakes no obligation to update the FAQs. Investors are advised to note the date of the information when referring to the FAQs or other historical data.

MRK 8-K: Regulation FD — May 29, 2008

Summary

This Merck & Co., Inc. (MRK) 8-K filing from May 2008 is primarily informational, referencing publicly available Frequently Asked Questions (FAQs) released by Schering-Plough Corporation on May 28, 2008. Merck is furnishing these FAQs as an exhibit, indicating their relevance to investors, likely in the context of ongoing industry developments or potential strategic considerations. Investors should note that this filing does not contain new financial results or specific operational updates directly from Merck, but rather points to external information provided by Schering-Plough.

Key Highlights

1Merck is furnishing Schering-Plough Corporation's May 28, 2008, FAQs to investors.
2The FAQs are available on the Schering-Plough website under Investor Relations/Investor FAQs.
3This filing serves as a disclosure mechanism under Regulation FD.
4No new financial statements or specific operational disclosures are provided by Merck in this report.
5Investors are directed to the Schering-Plough website for the detailed FAQs.
6Merck explicitly states no obligation to update the furnished FAQs.
7Emphasis is placed on the date of the information when reviewing the FAQs.